Author： Svahn Tiffany H. Niland Joyce C. Carlson Robert W. Hughes Melissa E. Ottesen Rebecca A. Theriault Richard L. Edge Stephen B. Schott Anne F. Bookman Michael A. Weeks Jane C.
Publisher： Cambridge Scholars Publishing in association with GSE Research
ISSN： 1540-1405
Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.7, Iss.2, 2009-02, pp. : 115-121
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Breast cancer adjuvant therapy use increases in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 367, 2002-01 ,pp. :
Use of LHRH-agonists as adjuvant therapy for breast cancer
By Cuzick Jack
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. :
Melatonin and Aromatase in Breast Cancer
Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. :
Melatonin and Aromatase in Breast Cancer
Clinical Cancer Drugs, Vol. 1, Iss. 1, 2013-12 ,pp. :